MTNB vs TECH
Matinas BioPharma Holdings Inc (MTNB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MTNB currently screens at market cap $5.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MTNB and TECH stock pages for the full models.
Not investment advice.